For help on how to get the results you want, see our search tips.
339 results
Medicine
Maximum residue limits Remove Maximum residue limits filter
Withdrawn applications Remove Withdrawn applications filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Summary of opinion: Herwenda (new)
trastuzumab, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Vanflyta (new)
quizartinib, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Nordimet (new)
methotrexate, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Ryeqo (new)
relugolix, estradiol, norethisterone acetate, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Voxzogo (new)
vosoritide, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: ZILBRYSQ (new)
Zilucoplan, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Ebglyss (new)
Lebrikizumab, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Aqumeldi (new)
Enalapril maleate, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Olumiant (new)
baricitinib, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Enhertu (new)
trastuzumab deruxtecan, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Withdrawn application: Zefylti
filgrastim, date of withdrawal: 08/06/2023, Initial authorisation, Last updated: 30/08/2023 -
List item
Withdrawn application: Lagevrio
molnupiravir, date of withdrawal: 21/06/2023, Initial authorisation, Last updated: 09/08/2023 -
List item
Withdrawn application: Lumevoq
lenadogene nolparvovec, date of withdrawal: 20/04/2023, Initial authorisation, Last updated: 08/08/2023 -
List item
Withdrawn application: Susvimo
ranibizumab, date of withdrawal: 02/05/2023, Initial authorisation, Last updated: 18/07/2023 -
List item
Withdrawn application: Feraheme
ferumoxytol, date of withdrawal: 09/03/2023, Initial authorisation, Last updated: 11/07/2023 -
List item
Withdrawn application: Asimtufii
aripiprazole, date of withdrawal: 02/05/2023, Initial authorisation, Last updated: 07/07/2023 -
List item
Withdrawn application: Tidhesco
ivosidenib, date of withdrawal: 27/03/2023, Initial authorisation, Last updated: 21/06/2023 -
List item
Withdrawn application: Buvidal
buprenorphine, date of withdrawal: 13/02/2023, Post-authorisation, Last updated: 14/06/2023 -
List item
Withdrawn application: Raltegravir Viatris
raltegravir potassium, date of withdrawal: 22/02/2023, Initial authorisation, Last updated: 21/04/2023 -
List item
Withdrawn application: Ilaris
canakinumab, date of withdrawal: 26/10/2022, Post-authorisation, Last updated: 23/02/2023 -
List item
Withdrawn application: Aliqopa
copanlisib, date of withdrawal: 20/12/2021, Initial authorisation, Last updated: 10/02/2023 -
List item
Withdrawn application: Miplyffa
arimoclomol, date of withdrawal: 22/03/2022, Initial authorisation, Last updated: 08/02/2023 -
List item
Withdrawn application: Imbarkyd
bardoxolone methyl, date of withdrawal: 09/11/2022, Initial authorisation, Last updated: 07/02/2023 -
List item
Withdrawn application: Gavreto
pralsetinib, date of withdrawal: 03/11/2022, Post-authorisation, Last updated: 02/02/2023 -
List item
Withdrawn application: Olumiant
baricitinib, date of withdrawal: 07/12/2022, Post-authorisation, Last updated: 02/02/2023